UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003442
Receipt number R000004073
Scientific Title Evaluation of Defibrillation SAfety with the Increased Number of Sensing to Reduce ShocKS for Ventricular Tachyarrhythmia in Japanese ICD Patients
Date of disclosure of the study information 2010/04/02
Last modified on 2012/07/27 09:28:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of Defibrillation SAfety with the Increased Number of Sensing to Reduce ShocKS for Ventricular Tachyarrhythmia
in Japanese ICD Patients

Acronym

SANKS study

Scientific Title

Evaluation of Defibrillation SAfety with the Increased Number of Sensing to Reduce ShocKS for Ventricular Tachyarrhythmia
in Japanese ICD Patients

Scientific Title:Acronym

SANKS study

Region

Japan


Condition

Condition

ICD or CRT-D cases

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

1) To evaluate non-inferiority of VT/VF termination rate with NID:30/40 to 18/24
2) To evaluate the efficacy of prolonged NID on the inappropriate shock reduction by analyzing retrospective EGM data.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

a, VF termination rate by ICD shock therapy in VF induction test.
b, Inappropriate shock reduction rate by simutating NID as 30/40.

Key secondary outcomes

Time from VF induction and detection to VF termination.


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

VT/VF detection parameter: 18/24

Interventions/Control_2

VT/VF detection parameter: 30/40

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) ICD/CRT-D patients
2) Patients whoes clinical condition are stable.
3) Patients who are able to receive VF induction tests.
4) Patients who are able to conduct VF induction tests with 25J.
5) Patients who sign the informed consents.

Key exclusion criteria

1) Patients whoes clinical condition are not acceptable to VF induction tests.
2) Patients who are limited to participate this study due to their clinical condition.
3) Patients who can not sign the informed consents.

Target sample size

186


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tomoyuki Tejima

Organization

Medtronic Japan Co., Ltd.

Division name

CRDM

Zip code


Address

Comodio Shiodome 5F, 2-14-1 Higashi Shimbashi, Minato-ku, Tokyo

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name Tomoyuki Tejima

Organization

Medtronic Japan Co., Ltd.

Division name

CRDM

Zip code


Address


TEL


Homepage URL


Email



Sponsor or person

Institute

Medtronic Japan Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Medtronic Japan Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2010 Year 04 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 12 Month 24 Day

Date of IRB


Anticipated trial start date

2010 Year 03 Month 01 Day

Last follow-up date

2012 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2010 Year 04 Month 02 Day

Last modified on

2012 Year 07 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004073


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name